Jubilant Pharmova Ltd (nse:JUBLPHARMA) Share Price

Company Profile

Business description
Jubilant Pharmova Ltd is an integrated pharmaceutical company. The company operates in the following segments; Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Contract Research, Development and Manufacturing Organisation; Generics; and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment which specializes in developing, manufacturing, commercializing, and distributing therapeutic agents in the nuclear medicine domain. Geographically, it derives a majority of its revenue from the Americas and Europe and the rest from India and the Rest of the world.
Contact
1A, Sector 16A
NoidaUP201301
IND
T: +91 1204361000
https://www.jubilantpharmova.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
6,386

Recommended

Shares have fallen over 40% this year but revenue is still growing quickly.

Roy Van Keulen | 10 November 2026

Store closures could hit landlords.

Yingqi Tan, CFA | 09 November 2026

Short term pain, long term potential.

Esther Holloway | 09 November 2026

Index	Last price	Change	% Change
All Ordinaries	9,291.30	23.50	0.25%
CAC 40	8,278.59	45.30	0.55%
DAX 40	26,347.45	80.26	0.31%
Dow JONES (US)	52,231.89	157.86	-0.30%
FTSE 100	10,751.59	31.28	-0.29%
HKSE	24,421.99	135.05	-0.55%
NASDAQ	25,065.87	187.27	-0.74%
Nikkei 225	61,337.79	878.21	1.45%
NZX 50 Index	14,179.86	12.45	0.09%
S&P 500	7,520.93	29.01	-0.38%
S&P/ASX 200	9,153.20	24.20	0.27%
SSE Composite Index	3,685.95	22.23	0.61%